These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28990236)

  • 41. "Non-Taxifolin" Derived Flavonolignans: Phytochemistry and Biology.
    Chambers CS; Valentova K; Kren V
    Curr Pharm Des; 2015; 21(38):5489-500. PubMed ID: 26429716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemistry of silybin.
    Biedermann D; Vavříková E; Cvak L; Křen V
    Nat Prod Rep; 2014 Sep; 31(9):1138-57. PubMed ID: 24977260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanistic Insights into the Pharmacological Significance of Silymarin.
    Wadhwa K; Pahwa R; Kumar M; Kumar S; Sharma PC; Singh G; Verma R; Mittal V; Singh I; Kaushik D; Jeandet P
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
    Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS
    Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Milk Thistle (Silybum marianum) Seed Cakes by Horses Subjected to Physical Exertion.
    Dockalova H; Baholet D; Batik A; Zeman L; Horky P
    J Equine Vet Sci; 2022 Jun; 113():103937. PubMed ID: 35318098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
    Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
    Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
    Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
    Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of polyamines in regulating silymarin production in Silybum marianum (L.) Gaertn (Asteraceae) cell cultures under conditions of calcium deficiency.
    Cacho M; Torres Domínguez A; Elena-Rosselló JA
    J Plant Physiol; 2013 Oct; 170(15):1344-8. PubMed ID: 23810612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced silymarin accumulation is related to calcium deprivation in cell suspension cultures of Silybum marianum (L.) Gaertn.
    Angeles Sánchez-Sampedro M; Fernández-Tárrago J; Corchete P
    J Plant Physiol; 2005 Oct; 162(10):1177-82. PubMed ID: 16255176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silymarin synthesis and degradation by peroxidases of cell suspension cultures of Silybum marianum.
    Sánchez-Sampedro MA; Fernández-Tárrago J; Corchete P
    J Plant Physiol; 2007 May; 164(5):669-74. PubMed ID: 16901583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Silybum marianum in vitro].
    Tůmová L; Gallová K; Rimáková J
    Ceska Slov Farm; 2004 May; 53(3):135-40. PubMed ID: 15218735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
    Kidd P; Head K
    Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silybin and silymarin--new effects and applications.
    Kren V; Walterová D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):29-41. PubMed ID: 16170386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic properties of milk thistle ecotypes from Iran for morphological and flavonolignans characters.
    Shokrpour M; Moghaddam M; Mohammadi SA; Ziai SA; Javanshir A
    Pak J Biol Sci; 2007 Oct; 10(19):3266-71. PubMed ID: 19090141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioconversion of silybin to phase I and II microbial metabolites with retained antioxidant activity.
    Abourashed EA; Mikell JR; Khan IA
    Bioorg Med Chem; 2012 May; 20(9):2784-8. PubMed ID: 22503365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New insight into the biosynthesis of flavanolignans in the white-flowered variant of Silybum marianum.
    Nyiredy S; Samu Z; Szücs Z; Gulácsi K; Kurtán T; Antus S
    J Chromatogr Sci; 2008 Feb; 46(2):93-6. PubMed ID: 18366865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
    Soleimani V; Delghandi PS; Moallem SA; Karimi G
    Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Yeast extract and methyl jasmonate-induced silymarin production in cell cultures of Silybum marianum (L.) Gaertn.
    Sánchez-Sampedro MA; Fernández-Tárrago J; Corchete P
    J Biotechnol; 2005 Sep; 119(1):60-9. PubMed ID: 16054261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chalcone synthase genes from milk thistle (Silybum marianum): isolation and expression analysis.
    Sanjari S; Shobbar ZS; Ebrahimi M; Hasanloo T; Sadat-Noori SA; Tirnaz S
    J Genet; 2015 Dec; 94(4):611-7. PubMed ID: 26690515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention.
    Graf TN; Wani MC; Agarwal R; Kroll DJ; Oberlies NH
    Planta Med; 2007 Nov; 73(14):1495-501. PubMed ID: 17948171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.